Artivion (AORT) Interest Coverage Ratio Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -7.80% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -1.00% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 12.94% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -35.05% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.28% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -4.98% |
| 10 | Artivion | 1.02 Bn | 961.00 Mn | 75.45 Mn | 54.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 54.70% |
| Dec 31, 2025 | 35.92% |
| Sep 30, 2025 | 63.83% |
| Jun 30, 2025 | 1.36% |
| Mar 31, 2025 | -12.26% |
| Dec 31, 2024 | 28.35% |
| Sep 30, 2024 | -47.38% |
| Mar 31, 2024 | 107.60% |
| Dec 31, 2023 | 7.65% |
| Sep 30, 2023 | -31.12% |
| Jun 30, 2023 | 62.95% |
| Mar 31, 2023 | -16.98% |
| Dec 31, 2022 | 30.29% |
| Sep 30, 2022 | -38.45% |
| Jun 30, 2022 | -13.50% |
| Mar 31, 2022 | -9.84% |
| Dec 31, 2021 | -5.81% |
| Sep 30, 2021 | 47.06% |
| Mar 31, 2021 | 33.57% |
| Dec 31, 2020 | 91.40% |
| Sep 30, 2020 | -8.69% |
| Jun 30, 2020 | -27.86% |
| Mar 31, 2020 | -28.55% |
| Dec 31, 2019 | 37.23% |
| Sep 30, 2019 | -43.85% |
| Jun 30, 2019 | -33.25% |
| Mar 31, 2019 | -60.65% |
| Jun 30, 2018 | 27.78% |
| Mar 31, 2018 | 73.69% |
| Jun 30, 2017 | 26.85% |
| Mar 31, 2017 | -51.45% |
| Dec 31, 2016 | -35.89% |
| Sep 30, 2016 | -55.37% |
| Jun 30, 2016 | -52.01% |
| Mar 31, 2016 | -48.06% |
| Jun 30, 2015 | -28.78% |
| Mar 31, 2015 | -59.62% |
| Jun 30, 2014 | -68.96% |
| Mar 31, 2014 | -20.60% |
| Dec 31, 2013 | -21.88% |
| Sep 30, 2013 | 40.85% |
| Jun 30, 2013 | 4.96% |